September 26, 2024 09:00 PM EDT
Startups
Special

End­points 11 win­ner Mi­rador Ther­a­peu­tics: Ap­ply­ing pre­ci­sion med­i­cine to im­mune dis­ease

Ryan Cross

Senior Science Correspondent

↑
  • CEO Mark McKen­na
  • To­tal raised $400 mil­lion
  • Head­quar­ters San Diego, CA

2024 is on track to be a record-break­ing year …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Steve Davis leaves Aca­dia, re­placed by Bris­tol My­ers alum; For­mer J&J ex­ec to lead R&D at No­vavax

The End­points 11 win­ners: Big bets on AI, new fron­tiers in edit­ing, a neu­ro re­nais­sance and Chi­nese chem­istry

No­vo Nordisk to de­crease some in­sulin pen man­u­fac­tur­ing, tran­si­tion sup­ply

Weight­Watch­ers re­places CEO who spear­head­ed its push in­to pre­scrip­tion weight loss drugs

FDA ap­proves Dupix­ent in COPD, open­ing ‘next chap­ter’ for Sanofi and Re­gen­eron’s best­seller

sponsored

PD­Cs vs. AD­Cs: A New Fron­tier in Tar­get­ed Can­cer Ther­a­pies and the Po­ten­tial for De­vel­op­ment Part­ner­ships

A service from the Financial Times